Nanovibronix Inc
Change company Symbol lookup
Select an option...
NAOV Nanovibronix Inc
ETON Eton Pharmaceuticals Inc
LXRX Lexicon Pharmaceuticals Inc
BVS Bioventus Inc
TDS-U Telephone and Data Systems Inc
ELEV Elevation Oncology Inc
FRZA Forza X1 Inc
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Price
Delayed
$3.33
Day's Change
-0.1377 (-3.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.36
Day's Low
3.33
Volume
(Average)

Today's volume of 1,219 shares is on pace to be in-line with NAOV's 10-day average volume of 6,672 shares.

1,219

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of DraftKings Inc. - DKNG

5:42 pm ET March 20, 2023 (Globe Newswire) Print
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of DraftKings Inc. - DKNGGlobeNewswireMarch 20, 2023

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DraftKings Inc. ("DraftKings" or the "Company") (NASDAQ: DKNG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether DraftKings and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On July 21, 2021, DraftKings announced its plan to launch DK Marketplace, a platform offering curated non-fungible token ("NFT") drops for U.S. dollar purchase and support for a secondary market transaction. The purpose of the DK Marketplace is to provide a platform to sell DraftKings NFTs. On August 11, 2021, DraftKings released its first NFTs, featuring the football player Tom Brady, which sold from $12 to $15,000 per NFT. A class action complaint has been filed against DraftKings and certain of its officers, alleging that DraftKings NFTs constitute unregistered securities, and that in DK Marketplace, DraftKings is operating an unregistered securities exchange.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com

888-476-6529 ext. 7980



comtex tracking

COMTEX_427105478/2010/2023-03-20T17:42:34

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.